Current studentsExisting staffContact us
 

Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the bench

Simple item page
dc.contributor.authorHui, C.
dc.contributor.authorHughes, T.
dc.date.issued2006
dc.description.statementofresponsibilityHui, Chi-hung; Hughes, Timothy P
dc.identifier.citationLeukemia and Lymphoma, 2006; 47(9):1721-1723
dc.identifier.doi10.1080/10428190600727871
dc.identifier.issn1042-8194
dc.identifier.issn1029-2403
dc.identifier.orcidHughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509]
dc.identifier.urihttp://hdl.handle.net/2440/34657
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.source.urihttps://doi.org/10.1080/10428190600727871
dc.subjectHumans
dc.subjectProto-Oncogene Proteins c-abl
dc.subjectGranulocyte Colony-Stimulating Factor
dc.subjectRecombinant Proteins
dc.subjectAdjuvants, Immunologic
dc.subjectHematopoietic Stem Cell Mobilization
dc.subjectCombined Modality Therapy
dc.subjectHematopoietic Stem Cell Transplantation
dc.subjectTransplantation, Autologous
dc.subjectLeukemia, Myelogenous, Chronic, BCR-ABL Positive
dc.subjectLenograstim
dc.titleAutologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the bench
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications